MEDIFAST INC
About MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
American Credentials
Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →
Financial summary
- Revenue FY2025
- $385.8M
- Net income
- -$18.7M
- Total assets
- $248.0M
- Market cap
- $134.5M
- Gross margin
- 71.3%
- Operating margin
- -3.7%
- Net margin
- -4.8%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $385.8M
- Cost of revenue
- $110.6M
- Gross profit
- $275.2M
- Operating expenses
- $289.4M
- Operating income
- -$14.2M
- Income tax
- $13.0M
- Net income
- -$18.7M
- EPS (basic)
- $-1.70
- EPS (diluted)
- $-1.70
Balance sheet
- Total assets
- $248.0M
- Current assets
- $201.7M
- Total liabilities
- $49.1M
- Current liabilities
- $43.0M
- Shareholders’ equity
- $198.9M
Cash flow
- Operating cash flow
- $6.9M
- Investing cash flow
- -$7.9M
- Financing cash flow
- -$564.0K
- Net cash flow
- -$1.6M
Statements via Polygon.io (SEC filings)
- Market cap
- $134.5M
- EPS (diluted)
- $-1.7
- Dividend yield
- 54.37%
- Shares outstanding
- 11.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Mar 24, 1981
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $18.7M in FY2025.
- Revenue declined 75% from FY2021 to FY2025.
- Gross margin of 71.3%, net margin -4.8%.
- Trading 20% below its 52-week high.
- Pays a dividend yielding about 54.37% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review MEDIFAST INC.
Write a review
News about MEDIFAST INC
News & sentiment via Polygon.io
